Berliner Boersenzeitung - Warmer noses are better at fighting colds: study

EUR -
AED 4.245913
AFN 76.887634
ALL 93.218842
AMD 422.094755
AOA 1060.176801
ARS 1724.882567
AUD 1.638747
AWG 2.082489
AZN 1.97002
BAM 1.955776
BBD 2.321671
BDT 142.688227
BHD 0.434695
BIF 3451.157116
BMD 1.156136
BND 1.477082
BOB 13.69983
BRL 5.876989
BSD 1.152686
BTN 109.688637
BWP 15.558807
BYN 3.432357
BYR 22660.258427
BZD 2.318271
CAD 1.61333
CDF 2615.761404
CHF 0.934181
CLF 0.026836
CLP 1056.199727
CNY 7.801146
CNH 7.796152
COP 3633.55485
CRC 523.993489
CUC 1.156136
CUP 30.637594
CVE 110.26363
CZK 24.258158
DJF 205.267449
DKK 7.477932
DOP 67.289164
DZD 152.967099
EGP 57.293288
ERN 17.342035
ETB 186.049588
FJD 2.553384
FKP 0.8566
GBP 0.856968
GEL 3.017966
GGP 0.8566
GHS 13.526832
GIP 0.8566
GMD 84.980421
GNF 10123.874202
GTQ 8.794891
GYD 241.157003
HKD 9.067746
HNL 30.895616
HRK 7.536622
HTG 150.718127
HUF 363.096405
IDR 20580.370421
ILS 3.468234
IMP 0.8566
INR 110.076256
IQD 1509.981237
IRR 1590322.371805
ISK 142.598215
JEP 0.8566
JMD 183.057725
JOD 0.819746
JPY 182.445186
KES 149.158147
KGS 101.104505
KHR 4681.941823
KMF 492.514185
KRW 1627.712241
KWD 0.356853
KYD 0.960588
KZT 540.233287
LAK 26025.676609
LBP 103223.017367
LKR 386.635196
LRD 208.057415
LSL 18.726567
LTL 3.413768
LVL 0.699335
LYD 7.331909
MAD 10.743067
MDL 20.044751
MGA 4918.938878
MKD 61.524236
MMK 2427.596601
MNT 4159.0218
MOP 9.314584
MRU 46.338424
MUR 54.419742
MVR 17.862733
MWK 1998.775164
MXN 19.811945
MYR 4.728715
MZN 73.882892
NAD 18.726567
NGN 1577.963717
NIO 42.419473
NOK 10.99759
NPR 175.501819
NZD 1.961547
OMR 0.442445
PAB 1.152686
PEN 3.903651
PGK 5.093937
PHP 70.183258
PKR 320.014324
PLN 4.299905
PYG 6853.914834
QAR 4.213648
RON 5.244583
RSD 117.338542
RUB 94.679224
RWF 1694.978938
SAR 4.345489
SBD 9.325039
SCR 16.705092
SDG 694.263698
SEK 10.961095
SGD 1.477661
SLE 28.445176
SOS 658.791814
SRD 43.778814
STD 23929.673396
STN 24.499696
SVC 10.085875
SZL 18.722767
THB 38.210709
TJS 10.633568
TMT 4.058036
TND 3.386358
TRY 55.144784
TTD 7.812903
TWD 37.286072
TZS 3051.762079
UAH 51.625959
UGX 4293.946644
USD 1.156136
UYU 46.399423
UZS 13785.828699
VES 873.763846
VND 30295.956222
VUV 138.059733
WST 3.160483
XAF 655.948849
XAG 0.018188
XAU 0.000266
XCD 3.124515
XCG 2.077474
XDR 0.81579
XOF 655.948849
XPF 119.331742
YER 275.626884
ZAR 18.667336
ZMK 10406.612213
ZMW 21.75673
ZWL 372.275202
  • CMSC

    0.0240

    21.744

    +0.11%

  • CMSD

    -0.1600

    21.82

    -0.73%

  • BCC

    2.3400

    86.6

    +2.7%

  • JRI

    0.1500

    12.81

    +1.17%

  • BCE

    -0.0200

    22.75

    -0.09%

  • RELX

    0.0485

    35.52

    +0.14%

  • RYCEF

    0.2300

    20.85

    +1.1%

  • RIO

    1.4500

    101.1

    +1.43%

  • RBGPF

    0.7600

    70.5

    +1.08%

  • NGG

    0.4700

    80.88

    +0.58%

  • VOD

    0.1900

    16.19

    +1.17%

  • BP

    -0.6000

    41.63

    -1.44%

  • GSK

    0.7900

    52.96

    +1.49%

  • BTI

    0.6000

    59.33

    +1.01%

  • AZN

    1.4100

    161.42

    +0.87%

Warmer noses are better at fighting colds: study
Warmer noses are better at fighting colds: study / Photo: Angela Weiss - AFP

Warmer noses are better at fighting colds: study

Chilly weather and common respiratory infections often go hand in hand.

Text size:

Reasons for this include people gather inside more in winter, and viruses survive better in low-humidity indoor air. But there has been less certainty about whether lower temperatures actually impair human immunity and, if so, how.

Now, a new study published Tuesday in The Journal of Allergy and Clinical Immunology details a previously unknown way that the immune system attacks viral intruders inside the nose -- and finds it works better when it's warm.

These discoveries could pave the way for an eventual treatment against the common cold and other viruses, Mansoor Amiji, a pharmaceutical sciences professor at Northeastern University, who co-led the research, told AFP.

The starting point was previous research by Amiji and colleagues in 2018, which found that nasal cells released "extracellular vesicles" (EVs) —- a spray of tiny sacs that swarmed and destroyed bacteria upon inhalation.

"The best analogy that we have is a hornet's nest," said Amiji. Like hornets defending a nest from attack, EVs swarm, bind to, and kill invaders.

For the new research, the team set out to answer two questions: are EVs also secreted in the nose in the presence of viral infections? And, if they are, is the strength of their response linked to temperature?

To answer the first question, they used a test substance which mimics a viral infection to stimulate nasal mucosa -- a thin tissue that lines the nose -- that was taken from volunteers who had surgery to remove polyps.

They found it did in fact produce EVs that target viruses.

In order to tackle the second question, they divided the nasal cell samples into two groups and cultured them in a lab, subjecting one set of samples to 37 degrees Celsius, and the other to 32C.

These temperatures were chosen based on a separate test that found the temperature inside the nose falls by about 5C when outside air drops from 23C to 4C.

Under regular body heat conditions, the EVs were successfully able to fight off viruses, by presenting them with "decoy" targets that they latch on to instead of the receptors they would otherwise target on cells.

But under the reduced temperatures, fewer EVs were produced, and those that were made packed less punch against the invaders tested: two rhinoviruses and a non-Covid coronavirus, which are typically found in winter cold season.

"There's never been a convincing reason why you have this very clear increase in viral infectivity in the cold months," said co-author Benjamin Bleier, a surgeon at Harvard Medical School and Massachusetts Eye and Ear, in a statement.

"This is the first quantitative and biologically plausible explanation that has been developed."

One of the most exciting aspects of the work is the potential to rev up the body's natural production of virus-targeting EVs in order to fight or even fend off the cold -- or even the flu and Covid, said Amiji.

"That's an area of great interest for us and we certainly continue to pursue that," he said.

(A.Lehmann--BBZ)